No Picture
Revive Therapeutics Ltd.

Revive Therapeutics and Ehave Enter Into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive“) (TSX-V:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and Ehave, Inc. (“Ehave”) (OTCQB:EHVVF), a healthcare company dedicated […]

No Picture
Revive Therapeutics Ltd.

Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th International Conference on Polyphenols and the 9th Tannin Conference

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, today announced that it has […]

No Picture
Revive Therapeutics Ltd.

Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases

TORONTO, Jan. 30, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, today announced the advancement of […]